LabGenius Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $13.5M

  • Investors
  • 34

LabGenius Therapeutics General Information

Description

Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease. The company's therapeutics engineer protein drugs properties, such as protease stability and tissue penetration, using their smart robotic platform to design, conduct, and critically learning from its experiments, enabling physicians to get access to protein therapeutics that are developed using robotic automation, synthetic biology, and advanced machine learning.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • G04 Cocoa Studios, The Biscuit Factory
  • 100 Drummond Road
  • London SE16 4DG
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • G04 Cocoa Studios, The Biscuit Factory
  • 100 Drummond Road
  • London SE16 4DG
  • England, United Kingdom
+44 020

LabGenius Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LabGenius Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 31-Jul-2025 $13.5M Completed Pre-Clinical Trials
9. Later Stage VC (Series B) 01-Apr-2024 Completed Pre-Clinical Trials
8. Grant 30-Nov-2022 Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 29-Oct-2020 Completed Pre-Clinical Trials
6. Grant 01-Jul-2020 Completed Pre-Clinical Trials
5. Seed Round 24-Nov-2017 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Startup
3. Grant 01-Oct-2017 Completed Startup
2. Grant 09-Dec-2015 $75.7K Completed Startup
1. Grant 01-Jun-2015 $30.9K Completed Startup
To view LabGenius Therapeutics’s complete valuation and funding history, request access »

LabGenius Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Series B2
Series B1
Series A2 Preferemce
Series A2 Preferemce
Series A1 Preference
Ordinary 173,900 $0.002532 $1.08 $1.08 1x $1.08 3.85%
Preference 228,322 $0.002532 $12.46 $12.46 1x $12.46 5.06%
To view LabGenius Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LabGenius Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease.
Drug Discovery
London, United Kingdom
70 As of 2026

Toronto, Canada
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LabGenius Therapeutics Competitors (21)

One of LabGenius Therapeutics’s 21 competitors is ProteinQure, a Venture Capital-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProteinQure Venture Capital-Backed Toronto, Canada
Genialis Venture Capital-Backed Boston, MA
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom
Numerion Labs Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 21 competitors. Get the full list »

LabGenius Therapeutics Patents

LabGenius Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3139359-A1 Methods and systems for protein engineering and production Pending 09-May-2019
EP-3966825-A1 Methods and systems for protein engineering and production Pending 09-May-2019
GB-201906566-D0 Methods and systems for protein engineering and production Inactive 09-May-2019
US-20220064634-A1 Methods and systems for protein engineering and production Pending 09-May-2019
WO-2020225576-A1 Methods and systems for protein engineering and production Inactive 09-May-2019 G16B35/10
To view LabGenius Therapeutics’s complete patent history, request access »

LabGenius Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LabGenius Therapeutics Investors (34)

Investor Name Investor Type Holding Investor Since Participating Rounds
Berggruen Holdings Family Office Minority
LG Holding Company Minority
Meltwind Advisory Venture Capital Minority
M Ventures Corporate Venture Capital Minority
Octopus Ventures Venture Capital Minority
You’re viewing 5 of 34 investors. Get the full list »

LabGenius Therapeutics FAQs

  • When was LabGenius Therapeutics founded?

    LabGenius Therapeutics was founded in 2012.

  • Where is LabGenius Therapeutics headquartered?

    LabGenius Therapeutics is headquartered in London, United Kingdom.

  • What is the size of LabGenius Therapeutics?

    LabGenius Therapeutics has 70 total employees.

  • What industry is LabGenius Therapeutics in?

    LabGenius Therapeutics’s primary industry is Drug Discovery.

  • Is LabGenius Therapeutics a private or public company?

    LabGenius Therapeutics is a Private company.

  • What is the current valuation of LabGenius Therapeutics?

    The current valuation of LabGenius Therapeutics is .

  • What is LabGenius Therapeutics’s current revenue?

    The current revenue for LabGenius Therapeutics is .

  • How much funding has LabGenius Therapeutics raised over time?

    LabGenius Therapeutics has raised $93.4M.

  • Who are LabGenius Therapeutics’s investors?

    Berggruen Holdings, LG, Meltwind Advisory, M Ventures, and Octopus Ventures are 5 of 34 investors who have invested in LabGenius Therapeutics.

  • Who are LabGenius Therapeutics’s competitors?

    ProteinQure, Genialis, Sygnature Discovery, Horizon Discovery, and Numerion Labs are some of the 21 competitors of LabGenius Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process